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ABSTRACT
Introduction: Patients with cerebral metastases from breast cancer have a very limited 
prognosis. Whole brain radiotherapy is a treatment option for these patients. Cranial irradiation 
can cause cerebrovascular disease years after treatment, but this is unusual in adults when 
only a low total dose is given. Furthermore, in most patients, survival is too short to develop 
cerebrovascular disease. 
Case Report: A 35-year-old woman diagnosed with breast cancer, developed pulmonary and 
cerebral metastases after initial treatment. After whole brain radiotherapy to a dose of 20 Gy 
in 4-Gy-fractions, followed by chemotherapy, she was in complete remission. After 20 years, 
she developed a stroke. Magnetic resonance imaging scan of the brain showed an ischemic 
lesion consistent with small vessel disease and also diffuse white matter injury. This is an 
atypical location for regular vascular disease, but it may be involved after cranial irradiation. Her 
hypertension was adequately treated. The patient lost weight and started with acetylsalicylic 
acid, dipyridamole and simvastatin. Despite these preventive measures, she had two more 
strokes within 18 months. Magnetic resonance imaging scan of the brain again showed ischemic 
lesions, consistent with small vessel disease. Her breast cancer remains in complete remission. 
Conclusion: This case describes an extraordinary long survival in a patient with breast cancer 
and visceral metastases. It shows that low dose cranial irradiation may contribute to intracerebral 
vasculopathy. Lifestyle interventions and regular checkups for risk factors of cardiovascular 
disease might be in place for patients with a long survival after cranial irradiation.
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AbstrAct
Introduction: Patients with cerebral metastases 
from breast cancer have a very limited prognosis. 
Whole brain radiotherapy is a treatment option 
for these patients. cranial irradiation can cause 
cerebrovascular disease years after treatment, 
but this is unusual in adults when only a low total 
dose is given. Furthermore, in most patients, 
survival is too short to develop cerebrovascular 
disease. case report: A 35-year-old woman 
diagnosed with breast cancer, developed 
pulmonary and cerebral metastases after initial 
treatment. After whole brain radiotherapy to 
a dose of 20 Gy in 4-Gy-fractions, followed by 
chemotherapy, she was in complete remission. 
After 20 years, she developed a stroke. Magnetic 
resonance imaging scan of the brain showed 
an ischemic lesion consistent with small vessel 
disease and also diffuse white matter injury. this 
is an atypical location for regular vascular disease, 
but it may be involved after cranial irradiation. 
Her hypertension was adequately treated. the 
patient lost weight and started with acetylsalicylic 
acid, dipyridamole and simvastatin. Despite 
these preventive measures, she had two more 
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long survival in a patient with breast cancer and 
visceral metastases. It shows that low dose cranial 
irradiation may contribute to intracerebral 
vasculopathy. Lifestyle interventions and regular 
checkups for risk factors of cardiovascular 
disease might be in place for patients with a long 
survival after cranial irradiation.
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IntroDuctIon
Breast cancer accounts for 10–20% of all cases 
of brain metastases [1]. Once brain metastases have 
developed, patients have a very limited prognosis and 
median survival is only 3–6 months, depending on 
age, Karnofsky performance score, extracranial disease 
status, number of brain metastases and administration of 
chemotherapy [1, 2]. 
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Treatment options that alleviate neurological 
symptoms and prolong survival are surgical resection, 
stereotactic radiosurgery (SRS), whole brain 
radiotherapy (WBRT), corticosteroids or a combination 
of these approaches. Surgery is an option in case of single 
metastasis and is usually followed by WBRT. Patients 
with an irresectable single metastasis, or up to four 
metastases can be eligible for SRS. Surgery or SRS are 
considered when a patient’s condition is good and the 
amount of extracranial disease is limited. For patients 
in a reasonable condition, WBRT alone is a good option. 
Corticosteroids can be used as a single treatment modality 
for patients in a poor condition, or in addition to other 
treatments [3]. 
After cranial irradiation coagulative necroses and 
demyelination of white matter have been observed [4, 5]. 
These histopathological changes can cause a spectrum of 
clinical syndromes long after cranial irradiation. Focal 
necrosis occurs between 6 months and 2 years after cranial 
irradiation and can be symptomatic [4, 5]. Diffuse white 
matter injury leads to symptoms like personality change 
and memory loss, with increasing severity of findings on 
magnetic resonance imaging (MRI) scan correlating with 
increasing severity of symptoms [5].
Cerebral blood vessel damage has been observed after 
cranial irradiation. In medium-sized and larger vessels 
intima thickening is the most prominent pathological 
change [6]. In large vessels myointimal proliferation 
has been found. In medium-sized vessels accumulation 
of foam cells in the intima and fibrosis of the adventitia 
have been observed. In smaller arteries, the main 
changes are subendothelial fibrosis, subendothelial foam 
cells, hyaline medial change and adventitial fibrosis and 
eventually obliteration of the arteriolar lumen [7]. 
Cerebrovascular disease after cranial irradiation 
has historically been described in children, primarily 
following parasellar radiotherapy [5]. It usually 
presents as progressive occlusion of the intracranial 
vessels, including Moyamoya syndrome, which can 
result in stroke. Moyamoya syndrome is characterized 
by abnormal collateral vascular networks, which arise 
adjacent to spontaneously occluded vessels of Willis’ 
circle [8]. A recent review found 54 documented cases of 
Moyamoya syndrome after cranial irradiation [8]. Median 
age at initial radiotherapy was 3.8 years (range 0.4–47 
years). Average dose was 55.2 Gy (range 22–120 Gy). The 
only four patients with Moyamoya syndrome after doses 
<30 Gy were <7 years old at the time of radiotherapy, 
suggesting a possible dose-response relationship and that 
younger children might be more sensitive. A review on 
cerebral occlusive disease after cranial irradiation found 
that 77% of the cases were <18 years old at the time of 
radiotherapy [9]. A chart review of 345 children treated 
with radiotherapy for a primary brain tumor reported 
Moyamoya syndrome in 12 children is 3.5% [10]. The 
onset of Moyamoya syndrome was more rapid for patients 
receiving >50 Gy (42 vs 67 months). Each 1-Gy increase 
in dose increased the rate of Moyamoya syndrome by 7%. 
For adults, there are less reports of cerebrovascular 
disease after cranial irradiation. A recent chart review of 
patients treated with radiotherapy for pituitary adenomas 
described a cerebrovascular event in 78 of 385 patients 
(20.3%), 0.6–27.4 years after radiotherapy. Median age 
at the time of radiotherapy was 54 years (range 14–82 
years) and median age at the time of stroke was 70 years. 
Risk of stroke was 1.45 times the expected rate for men and 
2.22 for women [11]. In a similar study, a relative risk of 
cerebrovascular accidents of 4.1 was found, also in patients, 
mainly adults, treated with radiotherapy for pituitary 
adenoma. Usual dose was 40–50 Gy in 20–30 fractions. 
Again, relative risk was higher for women than for men [12]. 
Based on these studies, we can conclude that it is 
likely that there is a dose-response relationship for 
cerebrovascular disease. Adults who receive cranial 
irradiation are likely to be at higher risk for stroke than 
the general population, but they seem to be less sensitive 
for developing cerebrovascular disease after cranial 
irradiation than children. 
cAsE rEPort
In 1984, a 35-year-old woman was diagnosed with a 
pT2N0M0 medullary carcinoma of the right breast, for 
which a modified radical mastectomy was performed. 
No additional treatments were given. Three years later, 
she started having difficulty with the coordination 
of her right hand and noticed a light paresis of the 
right arm. She had also coughed up blood recently. 
Cerebral computed tomography (CT) scan showed 
three metastases. A chest X-ray showed mediastinal 
enlargement and an intrapulmonary lesion. Sputum 
analysis revealed malignant cells of an adenocarcinoma, 
most likely originating from the earlier diagnosed breast 
cancer. She was treated with WBRT to a dose of 20 Gy 
in 4-Gy-fractions. This was followed by six courses of 
cyclophosphamide, methotrexate and 5-fluorouracyl. A 
new chest X-ray and cerebral CT scan showed a complete 
remission. 
At the age of 58, the patient developed short-term 
memory loss, attention deficit, balance problems and 
an episode of dysarthria. Cerebral magnetic resonance 
imaging (MRI) scan showed an ischemic lesion in 
the right frontal lobe and diffuse white matter lesions 
(Figure 1). Intima thickening of both common carotid 
arteries was seen during duplex scanning as well as slight 
plaque build-up in the left internal carotid artery. The 
left vertebral artery had an abnormal flow, most likely 
due to hypoplasia. No significant stenoses were found. 
An electrocardiography (ECG) showed a sinus rhythm. 
Laboratory tests revealed normal glucose, cholesterol, 
folic acid, vitamin B1, B6 and B12 levels. Tests for 
antinuclear antibodies and antineutrophil cytoplasmic 
antibodies were negative. Hypertension was diagnosed, 
the patient was overweight, and she had never smoked. 
We concluded that this ischemic stroke had been 
IJCRI – International Journal of Case Reports and Images, Vol. 5 No. 01, January 2014. ISSN – [0976-3198]
IJCRI 2014;5(1):32–35.  
www.ijcasereportsandimages.com
Meijer et al. 34
caused by small vessel disease. To prevent a second 
stroke, lisinopril, acetylsalicylic acid, dipyridamole and 
simvastatin were started.  She was advised to lose weight.
Four months later, she had sudden complaints of 
paresis and coordination problems of the left hand and 
balance problems. Laboratory tests, an ECG, a cerebral 
CT scan and a new carotid and vertebral duplex scan 
showed no changes. Less than a year later she noticed 
sudden progression of her balance problems with paresis 
of the left leg and left sided ptosis and facial nerve 
paralysis. Her third acute ischemic stroke was diagnosed. 
A magnetic resonance angiography (MRA) showed three 
new ischemic lesions paraventricular, increase of white 
matter lesions and strongly diminished contrast filling of 
left vertebral artery due to stenosis or hypoplasia. 
The complaints have improved with physiotherapy 
and speech therapy. Her breast cancer remains in 
complete remission.
also be a late effect of radiotherapy, as there were also 
diffuse white matter changes in the cerebellum, which 
are atypical for white matter changes due to vascular 
problems. One might argue that a hypercoagulable state 
due to cancer may have played a role here. However, this 
seems unlikely, as this patient had been without evidence 
of disease for many years. She has two other risk factors 
for small vessel disease: she was overweight and had 
hypertension. These might have also caused the plaque 
build-up in the left internal carotid artery. Nevertheless, 
as small vessel vasculopathy is progressive in time after 
radiotherapy, it is likely that WBRT did contribute to the 
small vessel disease, even though a relatively low total 
dose was given. 
concLusIon
This case shows an extraordinary long survival in 
a patient with pulmonary and brain metastases from 
breast cancer. It also shows that radiotherapy to the brain, 
even in a low dose, might contribute to intracerebral 
vasculopathy. Therefore, in patients with a long survival 
after cranial irradiation; even with low dose; lifestyle 
interventions such as regular check-up for risk factors 
of cardiovascular disease, might be essential to prevent 
stroke.
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Figure 1: (A) T2-flair magnetic resonance imaging scan showing 
the white matter injury in the cerebellum, (B) Diffusion-
weighted magnetic resonance imaging scan showing the 
ischemic lesion in the right frontal lobe.
DIscussIon
This case shows an extraordinary long survival in a 
patient with cerebral and pulmonary metastases of breast 
cancer. Further, stroke after low dose radiotherapy is 
highly unusual in adults. 
In our patient, intima thickening of the common 
carotid artery was seen at duplex scanning. The thickening 
was probably not caused by irradiation, as the common 
carotid arteries were outside the radiation fields. Further, 
common carotid artery occlusion cannot be linked to the 
location of the ischemic lesions in the brain. The observed 
left vertebral artery hypoplasia is not likely to be the 
cause of the stroke, as ischemic lesions seen on MRI scan 
were not in the blood supply region of this artery. Thus, 
since we observed no vascular lesions in large arteries 
consistent with the location of ischemia, we concluded 
the recurrent strokes were caused by small vessel disease, 
which should probably be attributed to the prior low dose 
radiotherapy. The diffuse white matter changes might 
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